VTA and the Papez circuit (hypothalamus-mammillary bodies, mamillo-thalamic tract, anterior thalamic nuclei, cingulate cortex and hippo/parahippocampus), implicated in reward-motivated learning and memory processing, 4 appeared to be involved in these processes. Activation in the septal region in placebo nonresponders recalling was also observed. If confirmed, this effect would be consistent with the memory impairment observed after intraseptal m-opioid agonist administration, 9 through inhibition of the septohippocampal GABAergic neurons.
Current estimates of the heritability of autism spectrum disorders (ASD) derived from existing clinical twin studies 1--4 are potentially confounded by a number of factors, including low sample size, inconsistency in case definition and the role of de novo mutation (currently estimated to contribute to some 20% of cases), and the possibility that heritable causes of ASD in a twin could result in environmentally engendered affectation of a non-identical co-twin in utero, especially if mediated by humoral or immune mechanisms. To minimize these confounds, we compared autism recurrence in half siblings versus that in full siblings, using data (6 June 2011) from over five thousand families enrolled in the Interactive Autism Network (IAN), a national volunteer register for ASD, detailed characteristics of which have been previously described by our group. 5, 6 Recurrence rate among full siblings was observed to be approximately twice that among half siblings, providing strong evidence of genetic transmission of ASD.
The data included 5237 families with (a) an ASD-affected child and (b) at least one additional sibling. Among these, 619 included at least one maternal half-sibling, 55 included a paternal halfsibling and 4832 contained at least one full sibling of an ASD proband. A maximum of one full sibling and one maternal half sibling per family (selected at random in families in which more were available) were incorporated into the analysis. Sample characteristics are provided in Supplementary Table 1 .
The recurrence rate was 0.052 for maternal half siblings (0.081 for males, 0.020 for females), 0.00 for the small number of paternal half siblings and 0.095 for full siblings (0.141 for males, 0.050 for females). There was no difference in the full sibling recurrence rate in families with additional half siblings (0.100) compared with those without. The full sib recurrence rate is in agreement with numerous prior studies of sibling recurrence for categorical ASD-affectation status among school-aged children using modern categorical case definitions. 5 In a logistic regression model adjusting for sibling type (full versus maternal half sibling), gender and difference in age between proband and sib, gender (Po0.0001) and sibling type (P ¼ 0.004) were highly statistically significant, with a calculated point estimate (for risk incurred by half sibling status in comparison to full sibling status) of 0.56, and a 95% confidence interval of 0.38--0.83.
Structural equation modeling generated robust heritability estimates of 50--70% over a broad range of assumptions for population prevalence (Figure 1 and Supplementary Table 2 ). 
Letters to the Editor
For this analysis, we implemented the commonly used bivariate probit model, with the correlation in liability defined as r g ¼ a g A þ C, where a g is 1/4 for half-siblings and 1/2 for full siblings. A and C are additive genetic and shared environment effects, subject to the restriction that A þ C o1. Although in IAN, data are not available on the precise allocation of time spent by maternal half-sibs in the household of the proband, we allowed for sharing of rearing environment as mothers overwhelmingly maintain legal guardianship and primary custodianship of maternal half siblings through the time of the usual age of onset of ASD.
We replicated these findings in an independent sample of ASDaffected families oversampled for minority status in the US Autism Centers of Excellence data collection (Supplementary Table 1 ). The sample included 132 full siblings, 41 maternal half siblings and 31 paternal half siblings known to have been reared in the household of their respective ASD-affected proband. In this study, all siblings were screened for current ASD symptomatology using the Social Responsiveness Scale 7 and affectation status was confirmed using the Autism Diagnostic Interview-Revised. 8 Recurrence rates in this replication sample, 0.073 for maternal half siblings and 0.114 for full siblings, were remarkably consistent with those derived from the larger IAN sample. This analysis thus addresses several limitations of the IAN data set including: under-representation of minority subjects, the possibility of incomplete ascertainment of case status when relying on community diagnosis and the unavailability of data regarding time spent in the household of the proband.
To our knowledge this is the first report of the half-sibling: full-sibling recurrence ratio from a large population of families affected by autism. We note that in the two largest published clinical twin studies of autism, 1, 3 involving, respectively, 277 twin pairs ascertained in the same manner and from the same registry described here (IAN) and 192 twin pairs from the California Twin Registry, recurrence rates on the order of 0.30 were reported for male-male dizygotic twin pairs---over double what we observed here for non-twin siblings. The discrepancy between the recurrence rate for dizygotic twins and the rate for non-twin siblings (as reported here and elsewhere 5, 9 ) remains unexplained and requires further study to confirm and conclusively document the magnitude of the difference, but suggests the possibility that one mechanism by which genetic variation might incur risk for ASD in a fetus is through elicitation of deleterious maternal antibodies or other circulating factors, which---in twins but not sib pairs---could theoretically incur risk to the co-twin (irrespective of the genetic susceptibility status of the latter).
Given that an estimated 10--25% of the remaining causal variance is explainable on the basis of de novo mutation, 10 these data substantially contribute to the information base on the genetic structure of autism and strongly support a major role of genetic factors in the ontogeny of ASD, including the intergenerational transmission of additive genetic susceptibility factors through unaffected mothers. In 2005, we selected 10 genes for which there was reasonable evidence for involvement in the etiology of schizophrenia (COMT, DAOA, DISC1, DRD2, DRD3, DTNBP1, HTR2A, NRG1, SLC6A3 and SLC6A4, Supplementary Table S1).
1 Although these genes have not received support from far larger and comprehensive subsequent studies, and may not contain common etiological variations, 2 it is possible that they contain uncommon variations of etiological importance. To test this hypothesis, we conducted a multistage resequencing study.
In stage 1, we used Sanger methods to sequence the exons, 5 0 and 3 0 untranslated regions, splice sites, promoters and conserved intronic regions of these 10 genes in 727 cases with schizophrenia from CATIE 3 and 733 controls of European (EUR) and African (AFR) ancestry. In stage 2, we validated single-nucleotide variants (SNVs) using Roche 454 sequencing in the same samples. In stage 3, we genotyped prioritized SNVs in independent samples (Supplementary Material and Supplementary Figure S1) .
In stage 1, Sanger sequencing identified 782 variants, including 587 novel SNVs that are not found in dbSNP132 (Supplementary  Tables S2 --S4) . As expected, the number of novel variants discovered per individual was higher in those of AFR (1.46) than EUR ancestry (0.95), but cases and controls did not differ (EUR cases/controls: 0.920/0.980; AFR cases/controls: 1.492/1.430). The numbers of SNVs per gene were also similar, although DISC1
